linrodostat   Click here for help

GtoPdb Ligand ID: 9707

Synonyms: BMS-986205 | BMS986205 | Compound 2 [PMID: 29531094] | Example 19 [US20160137652A1]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Linrodostat (BMS-986205) is a potent and selective, orally available indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor [3], being investigated as an immuno-therapeutic for various malignancies. The INN for linrodostat specifies the (R) stereoisomer. The chemical structure is claimed as example 19 in Flexus Bioscience's patent US2016137652 [1] and the compound is being taken through clinical development by Bristol-Myers Squibb. Mechanistically, linrodostat competes with the heme cofactor for binding to the apo-form of the enzyme, and once bound prevents heme from rebinding [3].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 41.99
Molecular weight 410.16
XLogP 6.53
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc(cc1)NC(=O)C(C1CCC(CC1)c1ccnc2c1cc(F)cc2)C
Isomeric SMILES Clc1ccc(cc1)NC(=O)[C@@H](C1CCC(CC1)c1ccnc2c1cc(F)cc2)C
InChI InChI=1S/C24H24ClFN2O/c1-15(24(29)28-20-9-6-18(25)7-10-20)16-2-4-17(5-3-16)21-12-13-27-23-11-8-19(26)14-22(21)23/h6-17H,2-5H2,1H3,(H,28,29)/t15-,16?,17?/m1/s1
InChI Key KRTIYQIPSAGSBP-KLAILNCOSA-N
References
1. Beck HP, Jaen JC, Osipov M, Powers JP, Reilly MK, Shunatona HP, Walker JR, Zibinsky M, Balog JA, Williams DK et al.. (2016)
Immunoregulatory agents.
Patent number: US2016137652. Assignee: Flexus Biosciences, Inc.. Priority date: 05/11/2014. Publication date: 19/05/2016.
2. Li F, Zhang R, Li S, Liu J. (2017)
IDO1: An important immunotherapy target in cancer treatment.
Int Immunopharmacol, 47: 70-77. [PMID:28365507]
3. Nelp MT, Kates PA, Hunt JT, Newitt JA, Balog A, Maley D, Zhu X, Abell L, Allentoff A, Borzilleri R et al.. (2018)
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.
Proc Natl Acad Sci USA, 115 (13): 3249-3254. [PMID:29531094]